Cargando…

Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study

BACKGROUND: Poor adherence to inhaled therapy is common in patients with asthma and COPD. An inhaler selection based on patients’ preference could be beneficial to adherence and treatment effectiveness. Properly designed questionnaires can assess patients’ satisfaction with their medication devices....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zervas, Eleftherios, Samitas, Konstantinos, Gaga, Mina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981170/ https://www.ncbi.nlm.nih.gov/pubmed/27540287 http://dx.doi.org/10.2147/COPD.S113870

Ejemplares similares

Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
por: Samitas, Konstantinos, et al.
Publicado: (2015)

Clinical asthma phenotypes in the real world: opportunities and challenges
por: Bostantzoglou, Clementine, et al.
Publicado: (2015)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Breathing for two: pregnancy, asthma and respiratory failure
por: Gaga, Mina, et al.
Publicado: (2014)

Activin-A is up-regulated in severe asthma, attenuates allergic responses and is associated with angiogenesis
por: Samitas, Konstantinos, et al.
Publicado: (2013)

Introducing transbronchial cryobiopsies in diagnosing diffuse parenchymal lung diseases in Greece: Implementing training into clinical practice
por: Samitas, Konstantinos, et al.
Publicado: (2019)

Genetics and Epigenetics in Asthma
por: Ntontsi, Polyxeni, et al.
Publicado: (2021)

Successful and safe treatment of severe steroid depended eosinophilic asthma with mepolizumab in a woman during pregnancy
por: Vittorakis, Stylianos K., et al.
Publicado: (2022)

Control of asthma in real life: still a valuable goal?
por: Papaioannou, Andriana I., et al.
Publicado: (2015)

Circulating Conventional and Plasmacytoid Dendritic Cell Subsets Display Distinct Kinetics during In Vivo Repeated Allergen Skin Challenges in Atopic Subjects
por: Vittorakis, Stelios, et al.
Publicado: (2014)

Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2021)

Ovipositional Preferences of Two Squash Bug Species, Anasa tristis and Anasa armigera (Heteroptera: Coreidae), for Different Cultivars and Species of Cucurbitaceae
por: Cornelius, Mary L
Publicado: (2018)

In vitro dose comparison of Respimat(®) inhaler with dry powder inhalers for COPD maintenance therapy
por: Ciciliani, Anna-Maria, et al.
Publicado: (2017)

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
por: Svedsater, Henrik, et al.
Publicado: (2013)

Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Clinical utility of thoracic endosonography (EBUS/EUS-b) in mediastinal staging of patients with non-small cell lung cancer: comparison with integrated PET/CT—a real-life prospective study in Greece
por: Chrysikos, Serafeim, et al.
Publicado: (2020)

In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)
por: Hamilton, Melanie, et al.
Publicado: (2015)

Use of Flowering Plants to Enhance Parasitism and Predation Rates on Two Squash Bug Species Anasa tristis and Anasa armigera (Hemiptera: Coreidae)
por: Cornelius, Mary L., et al.
Publicado: (2019)

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
por: Leving, Marika T., et al.
Publicado: (2022)

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
por: Crim, Courtney, et al.
Publicado: (2019)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation
por: Man, Kwun Nok Mimi, et al.
Publicado: (2018)

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
por: Tzanakis, Nikolaos, et al.
Publicado: (2022)

The Diskus™: a review of its position among dry powder inhaler devices
por: Chrystyn, H
Publicado: (2007)

Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD
por: Chapman, Kenneth R, et al.
Publicado: (2011)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD
por: Jõgi, Rain, et al.
Publicado: (2021)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
por: Prime, David, et al.
Publicado: (2015)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
por: Caramori, Gaetano, et al.
Publicado: (2014)

Do Face-to-Face Training and Telephonic Reminder Improve Dry Powder Inhaler Technique in Patients with COPD?
por: Poudel, Ramesh Sharma, et al.
Publicado: (2017)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)

Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study
por: Ramadan, Wijdan H, et al.
Publicado: (2017)

Ease-of-use preference for the ELLIPTA(®) dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
por: Komase, Yuko, et al.
Publicado: (2014)

Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population
por: Rajan, Sujeet K., et al.
Publicado: (2014)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

Análisis del ciclo meiotico en anasa litigiosa stal (hemiptera: coreidae) /
por: Ramírez Rosales, Joiarib
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_7mvt38kd7ndhpct7n2oifds5g8